By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Norwegian biotech firm Hunt Biosciences and Boulder, Col.-based SomaLogic today announced a collaboration to validate protein biomarkers with an initial focus on the prediction of cardiovascular events.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.